Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection

American Journal of Tropical Medicine and Hygiene

Volumn 63, Issue 3-4, 2000, Pages 133-138

  Hodder, Sally L ^a   Mahmoud, Adel A F ^b   Sorenson, Kelly ^a   Weinert, Dayna M ^c   Stein, Richard L ^a   Ouma, John H ^d   Koech, Davy ^e   King, Charles H ^f  

^a Merck and Co ^*

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d Division of Vector Borne Diseases   (Kenya)

^e KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SCREENING; CHILD; CONTROLLED STUDY; CYTODIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INFANT; INFLAMMATION; KENYA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREVALENCE; RISK FACTOR; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SQUAMOUS CELL METAPLASIA; ULTRASOUND; URINARY TRACT CARCINOMA; URINARY TRACT INFECTION; URINE CYTOLOGY; UROTHELIUM;

EID: 0034441652     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.63.133     Document Type: Article

References (45)

1. Mustacchi P, Shimkin MD, 1958. Cancer of the bladder and infestation with Schistosoma haematobium. J Natl Cancer Inst 20: 825-842.
2. Gelfand M, Weinberg RW, Castle WM, 1967. Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet i: 1249-1251.
3. Anjarwalla KA, 1971. Carcinoma of the bladder in the Coast Province of Kenya. East Afr Med J 48: 502-509.
4. Bowry TR, 1975. Carcinoma of bladder in Kenya. East Afr Med J 52: 356-364.
5. Lucas SB, 1982. Squamous cell carcinoma of the bladder and schistosomiasis. East Afr Med J 59: 345-351.
6. Elem B, Purohit R, 1983. Carcinoma of the urinary bladder in Zambia: a quantitative estimation of Schistosoma haematobium infection. Br J Urol 55: 275-278.
7. Kitinya JN, Lauren PA, Eshleman LJ, Paljarvi L, Tanaka K, 1986. The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of Schistosoma haematobium infection. Trans R Soc Trop Med Hyg 80: 935-939.
8. Thomas JE, Bassett MT, Sigola LB, Taylor P, 1990. Relationship between bladder cancer incidence, Schistosoma haematobium infection, and geographical region in Zimbabwe. Trans R Soc Trop Med Hyg 84: 551-553.
9. WHO, 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosoma, Liver Flukes and Helicobacter pylori. Geneva: World Health Organization.
10. Bedwani R, Renganathan E, El Kwhsky F, Braga C, Abu Seif HH, Abul Azm T, Zaki A, Franceschi S, Boffetta P, La Vecchia C, 1998. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77: 1186-1189.
11. Groeneveld AE, Marszalek WW, Heyns CF, 1996. Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa. Br J Urol 78: 205-208.
12. Christie JD, Crouse D, Kelada AB, Anis-Ishak E, Smith JH, Kamel IA, 1986. Patterns of Schistosoma haematohium egg distribution in the human lower urinary tract. III. Cancerous lower urinary tracts. Am J Trop Med Hyg 35: 759-764.
13. Foot NC, Papanicolaou GN, Holmquist ND, Seybolt JF, 1957. Exfoliative cytology of urinary sediments. Cancer 11: 127-137.
14. Saracki CT, McCormack LJ, Kiser WS, Hazard JB, McLaughlin TC, Belovich DM, 1971. Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1400 patients. J Urol 106: 761-764.
15. Elwi AM, Fam A, Ramzy I, 1962. Exfoliative cytology of the bilharzial ulcer and cancer of the urinary bladder. J Egypt Med Assoc 45: 235-243.
16. el-Bolkainy MN, Ghoneim MA, el-Morsey BA, Nasr SM, 1974. Carcinoma of bilharzial bladder. Diagnostic value of urine cytology. Urology 3: 319-323.
17. el-Bolkainy MN, Chu EW, Ghoneim MA, Ibrahim AS, 1982. Cytologic detection of bladder cancer in a rural Egyptian population infested with schistosomiasis. Acta Cytol 26: 303-310.
18. el-Bolkainy MN, Chu EW, Ghoneim MA, Raafat MM, Tawfik HN, el-Morsey BA, Aboul-Ela F, Dahaba NM, Ibrahim AS, 1984. Cellular dysplasia in urine: cytologic follow up study on 220 cases. J Egypt Natl Cancer Inst 1: 13-23.
19. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odhiambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Mackay W, Ransohoff D, Houser H, Koech D, Siongok TK, Mahmoud AAF, 1988. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 39: 295-305.
20. el Kholy H, Arap Siongok TK, Koech D, Sturrock RF, Houser H, King CH, Mahmoud AA, 1989. Effects of borehole wells on water utilization in Schistosoma haematobium endemic communities in Coast Province, Kenya. Am J Trop Med Hyg 41: 212-219.
21. Peters PAS, Mahmoud AAF, Warren KS, Ouma JH, Siongok TKA, 1976. Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ 54: 159-162.
22. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odhiambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Ransohoff D, Houser H, Koech D, Arap Siongok TK, Mahmoud AAF, 1990. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity. Am J Trop Med Hyg 42: 587-595.
23. Connery DB, 1953. Leukoplakia of the urinary bladder and its association with carcinoma. J Urol 69: 121-127.
24. King CH, Keating CE, Muruka JF, Ouma JH, Houser H, Siongok TK, Mahmoud AA, 1988. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg 39: 361-368.
25. Petersen RO, 1992. Urinary bladder. Petersen RO, Urologic Pathology. Philadelphia: Lippincott, 260-394.
26. Cariou G, Maaraoui N, Cortesse A, 1997. Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder? Prog Urol 7: 51-55.
27. Wiener HG, Mian C, Haitel A, Pycha A, Schatzl G, Marberger M, 1998. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol 159: 1876-1880.
28. Smith JH, Christie JD, 1986. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 17: 333-345.
29. Rosin MP, Anwar WA, Ward AJ, 1994. Inflammation, chromosomal instability and cancer: the schistosomiasis model. Cancer Res 54 (suppl): 1929s-1933s.
30. Rosin MP, El Din Zaki SS, Ward AJ, Anwar WA, 1994. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat Res 305: 283-292.
31. Delnay KM, Stonehill WH, Goldman H, Jukkola AF Dmochowski RR, 1999. Bladder histological changes associated with chronic indwelling urinary catheter. J Urol 161: 1106-1108.
32. Brand KG, 1979. Schistosomiasis-cancer: etiological considerations. Acta Trop 36: 203-214.
33. Cheever AW, Kuntz RE, Moore JA, Huang TC, 1988. Pathology of Schistosoma haematobium infection in the capuchin monkey (Cebus apella). Trans R Soc Trop Med Hyg 82: 107-111.
34. Broecker BH, Klein FA, Hackler RH, 1981. Cancer of the bladder in spinal cord injury patients. J Urol 125: 196-197.
35. Polsky MS, Weber CH Jr, Williams JE, Nikolewski RF, Barr MT, Ball TP Jr, 1976. Chronically infected and postdiversionary bladders: cytologic and histopathologic study. Urology 7: 531-535.
36. Reece RW, Koontz WW Jr, 1975. Leukoplakia of the urinary tract: a review. J Urol 114: 165-171.
37. Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP, Rossier AB, 1977. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118: 967-971.
38. Stonehill WH, Dmochowski RR, Patterson AL, Cox CE, 1996. Risk factors for bladder tumors in spinal cord injury patients. J Urol 155: 1248-1250.
39. Gentile JM, Brown S, Aardema M, Clark D, Blankespoor H, 1985. Modified mutagen metabolism in Schistosoma haematobium infected organisms. Arch Environ Health 40: 5-11.
40. Weitzman SA, Weitberg AB, Clark EP, Stossel TP, 1985. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 227: 1231-1233.
41. de Ridder D, van Poppel H, Demonty L, D'Hooghe B, Gonsette R, Carton H, Baert L, 1998. Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol 159: 1881-1884.
42. Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck III CH, Busch C, Shamaa M, Elbaz M, Nichols PW, Gonzalgo ML, Malmstrom P-U, Jones PA, 1995. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J Natl Cancer Inst 87: 1383-1393.
43. Warren W, Biggs PJ. El-Baz, M, Ghoneim MA, Stratton MR, Venitt S, 1995. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 16: 1181-1189.
44. Pode D, Golijanin D, Sherman Y, Lebensart P, Shapiro A, 1998. Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors. J Urol 159: 389-392; discussion 393.
45. Stampfer DS, Carpinito GA, Rodriguez-Villanueva J, Willsey LW, Dinney CP, Grossman HB, Fritsche HA, McDougal WS, 1998. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 159: 394-398.